Showing results (141-150 of 210) with videos related to

Sort By:
Pageof 21
Diabetes, Obesity & Metabolism|November 20, 2019
Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT-5): 52-week results from a randomized, open-label, phase III clinical trialEiichi Araki, Hirotaka Watada, Yasuko Uchigata, et al.
Journal of Diabetes Investigation|December 5, 2020
Clinical profiles of hyperglycemic crises: A single-center retrospective study from JapanTakeshi Nishikawa, Hiroyuki Kinoshita, Keiko Ono, et al.
Scientific Reports|October 21, 2016
Activation of heat shock response to treat obese subjects with type 2 diabetes: a prospective, frequency-escalating, randomized, open-label, triple-arm trialTatsuya Kondo, Rieko Goto, Kaoru Ono, et al.
Biochemical and Biophysical Research Communications|March 24, 2011
Voltage-gated K+ channel KCNQ1 regulates insulin secretion in MIN6 β-cell lineKazuya Yamagata, Takafumi Senokuchi, Meihong Lu, et al.
Diabetes, Obesity & Metabolism|March 5, 2019
Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52-week data from the PROVIDE studyEiichi Araki, Shizuya Yamashita, Hidenori Arai, et al.
Plos One|January 25, 2018
Identification of microRNA that represses IRS-1 expression in liverKaoru Ono, Motoyuki Igata, Tatsuya Kondo, et al.
Journal of Diabetes Investigation|May 21, 2014
Report of the committee on the classification and diagnostic criteria of diabetes mellitus, Yutaka Seino, Kishio Nanjo, et al.
Atherosclerosis|May 27, 2006
Troglitazone inhibits oxidized low-density lipoprotein-induced macrophage proliferation: impact of the suppression of nuclear translocation of ERK1/2Miyuki Yano, Takeshi Matsumura, Takafumi Senokuchi, et al.
Internal Medicine (Tokyo, Japan)|June 21, 2023
Autoimmune Polyglandular Syndrome Type 3 Complicated with IgG4-related DiseaseYusuke Murata, Masaki Haneda, Nobukazu Miyakawa, et al.
Diabetes Care|April 30, 2003
Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetesTakeshi Nishikawa, Takayuki Sasahara, Shinsuke Kiritoshi, et al.
Pageof 21